Hims & Hers Health, Inc. (HIMS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Hims & Hers Health, Inc. (HIMS) is up 3.3% since the beginning of the year. At $34 per share, HIMS is trading 52.4% below its 52-week high of $70. Investors who bought $1,000 worth of HIMS shares 5 years ago would now be looking at an investment worth $3,017.

Hims & Hers Health, Inc. (HIMS) has returned 3.30% so far this year and -47.77% over the past 12 months.

Based on dividend-adjusted daily data since Sep 13, 2019, HIMS's average daily return is +0.19%, while the average monthly return is +4.24%. At this rate, an investment would double in approximately 1.4 years.

Historically, 51% of months were positive and 49% were negative. The best month was Nov 2024 with a return of +71.1%, while the worst month was Feb 2026 at -46.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.

On a daily basis, HIMS closed higher 47% of trading days. The best single day was Mar 9, 2026 with a return of +40.8%, while the worst single day was Jun 23, 2025 at -34.6%.

Hims & Hers Health, Inc. has an annualized alpha of 36.29%, beta of 1.08, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since September 13, 2019.

• This stock captured 126.91% of S&P 500 Index gains and 106.63% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

HIMS ranks 22 for risk / return — below 22% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Hims & Hers Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hims & Hers Health, Inc. was 87.29%, occurring on May 11, 2022. Recovery took 528 trading sessions.

The current Hims & Hers Health, Inc. drawdown is 51.21%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Hims & Hers Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Hims & Hers Health, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.